P A Meredith|H L Elliott - JoVE Visualize

Showing results (261-270 of 270) with videos related to

Pageof 27

Sort By:

You have reached the last page of results.This site can display upto 270 results.

Transplantation Proceedings|June 21, 2005

Circulating endothelial cells in renal transplant recipientsA S Mohamed, J Thomson, K J McDonald, et al.

Journal of Human Hypertension|October 1, 1991

Combined lipid-lowering and antihypertensive treatment as part of a strategy of multiple risk factor interventionN J Macdonald, E Farish, S Stark, et al.

Clinical Science (London, England : 1979)|February 1, 1986

Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in manC R Jones, M Giembcyz, C A Hamilton, et al.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999

Is cancer related to hypertension or to its treatment?A F Lever, D J Hole, C R Gillis, et al.

European Journal of Clinical Pharmacology|January 1, 1985

Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failureC W Howden, C D Payton, P A Meredith, et al.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989

Hypercholesterolaemia in treated hypertensives: a controlled trial of intensive dietary adviceJ L Curzio, S S Kennedy, H L Elliott, et al.

The Journal of Biological Chemistry|October 16, 1999

Platelet-derived growth factor stimulation of monocyte chemoattractant protein-1 gene expression is mediated by transient activation of the phosphoinositide 3-kinase signal transduction pathwayJ A Alberta, K R Auger, D Batt, et al.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999

Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?A F Lever, D G Beevers, D J Hole, et al.

Journal of Hypertension|April 9, 1998

Cancer risk of hypertensive patients taking calcium antagonistsD J Hole, C R Gillis, I R McCallum, et al.

Lancet (London, England)|July 31, 1998

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.

Pageof 27

Showing results (261-270 of 270) with videos related to

Sort By:

Pageof 27

You have reached the last page of results.This site can display upto 270 results.

Transplantation Proceedings|June 21, 2005

Circulating endothelial cells in renal transplant recipientsA S Mohamed, J Thomson, K J McDonald, et al.

Journal of Human Hypertension|October 1, 1991

Combined lipid-lowering and antihypertensive treatment as part of a strategy of multiple risk factor interventionN J Macdonald, E Farish, S Stark, et al.

Clinical Science (London, England : 1979)|February 1, 1986

Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in manC R Jones, M Giembcyz, C A Hamilton, et al.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999

Is cancer related to hypertension or to its treatment?A F Lever, D J Hole, C R Gillis, et al.

European Journal of Clinical Pharmacology|January 1, 1985

Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failureC W Howden, C D Payton, P A Meredith, et al.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989

Hypercholesterolaemia in treated hypertensives: a controlled trial of intensive dietary adviceJ L Curzio, S S Kennedy, H L Elliott, et al.

The Journal of Biological Chemistry|October 16, 1999

Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999

Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?A F Lever, D G Beevers, D J Hole, et al.

Journal of Hypertension|April 9, 1998

Cancer risk of hypertensive patients taking calcium antagonistsD J Hole, C R Gillis, I R McCallum, et al.

Lancet (London, England)|July 31, 1998

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.

Pageof 27